Literature DB >> 19650818

Stimulation of 5-HT(1B) receptors enhances cocaine reinforcement yet reduces cocaine-seeking behavior.

Nathan S Pentkowski1, Jazmin I Acosta, Jenny R Browning, Elizabeth C Hamilton, Janet L Neisewander.   

Abstract

Paradoxically, stimulation of 5-HT(1B) receptors (5-HT(1B)Rs) enhances sensitivity to the reinforcing effects of cocaine but attenuates incentive motivation for cocaine as measured using the extinction/reinstatement model. We revisited this issue by examining the effects of a 5-HT(1B)R agonist, CP94253, on cocaine reinforcement and cocaine-primed reinstatement, predicting that CP94253 would enhance cocaine-seeking behavior reinstated by a low priming dose, similar to its effect on cocaine reinforcement. Rats were trained to self-administer cocaine (0.75 mg/kg, i.v.) paired with light and tone cues. For reinstatement experiments, they then underwent daily extinction training to reduce cocaine-seeking behavior (operant responses without cocaine reinforcement). Next, they were pre-treated with CP94253 (3-10 mg/kg, s.c.) and either tested for cocaine-primed (10 or 2.5 mg/kg, i.p.) or cue-elicited reinstatement of extinguished cocaine-seeking behavior. For reinforcement, effects of CP94253 (5.6 mg/kg) across a range of self-administered cocaine doses (0-1.5 mg/kg, i.v.) were examined. Cocaine dose-dependently reinstated cocaine-seeking behavior, but contrary to our prediction, CP94253 reduced reinstatement with both priming doses. Similarly, CP94253 reduced cue-elicited reinstatement. In contrast, CP94253 shifted the self-administration dose-effect curve leftward, consistent with enhanced cocaine reinforcement. When saline was substituted for cocaine, CP94253 reduced response rates (i.e. cocaine-seeking behavior). In subsequent control experiments, CP94253 decreased open-arm exploration in an elevated plus-maze suggesting an anxiogenic effect, but had no effect on locomotion or sucrose reinforcement. These results provide strong evidence that stimulation of 5-HT(1B)Rs produces opposite effects on cocaine reinforcement and cocaine-seeking behavior, and further suggest that 5-HT(1B)Rs may be a novel target for developing medications for cocaine dependence.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19650818      PMCID: PMC2846432          DOI: 10.1111/j.1369-1600.2009.00162.x

Source DB:  PubMed          Journal:  Addict Biol        ISSN: 1355-6215            Impact factor:   4.280


  56 in total

1.  Serotonin-1B receptor-mediated inhibition of [(3)H]GABA release from rat ventral tegmental area slices.

Authors:  Q S Yan; S E Yan
Journal:  J Neurochem       Date:  2001-11       Impact factor: 5.372

2.  Activation of 5-HT(1B) receptors in the nucleus accumbens reduces self-administration of amphetamine on a progressive ratio schedule.

Authors:  Paul J Fletcher; Arezou Azampanah; Karin M Korth
Journal:  Pharmacol Biochem Behav       Date:  2002-04       Impact factor: 3.533

3.  Stimulation of serotonin1B receptors induces conditioned place aversion and facilitates cocaine place conditioning in rats.

Authors:  Luigi Cervo; Marco Rozio; Charlotte Blanche Ekalle-Soppo; Francesco Carnovali; Elisabetta Santangelo; Rosario Samanin
Journal:  Psychopharmacology (Berl)       Date:  2002-07-17       Impact factor: 4.530

4.  Dopamine D3 receptor antagonism inhibits cocaine-seeking and cocaine-enhanced brain reward in rats.

Authors:  Stanislav R Vorel; Charles R Ashby; Mousumi Paul; Xinhe Liu; Robert Hayes; Jim J Hagan; Derek N Middlemiss; Geoffrey Stemp; Eliot L Gardner
Journal:  J Neurosci       Date:  2002-11-01       Impact factor: 6.167

5.  Anxiogenic-like effect of serotonin(1B) receptor stimulation in the rat elevated plus-maze.

Authors:  Daniel Lin; Loren H Parsons
Journal:  Pharmacol Biochem Behav       Date:  2002-04       Impact factor: 3.533

6.  Influence of individual differences and chronic fluoxetine treatment on cocaine-seeking behavior in rats.

Authors:  D A Baker; T L Tran-Nguyen; R A Fuchs; J L Neisewander
Journal:  Psychopharmacology (Berl)       Date:  2001-04       Impact factor: 4.530

7.  Role of 5-hydroxytryptamine1B receptors and 5-hydroxytryptamine uptake inhibition in the cocaine-evoked discriminative stimulus effects in rats.

Authors:  M Filip; E Nowak; I Papla; E Przegaliński
Journal:  J Physiol Pharmacol       Date:  2001-06       Impact factor: 3.011

8.  Serotonin depletion attenuates cocaine seeking but enhances sucrose seeking and the effects of cocaine priming on reinstatement of cocaine seeking in rats.

Authors:  L T Tran-Nguyen; J G Bellew; K A Grote; J L Neisewander
Journal:  Psychopharmacology (Berl)       Date:  2001-10       Impact factor: 4.530

9.  Modulation of the effects of cocaine by 5-HT1B receptors: a comparison of knockouts and antagonists.

Authors:  N Castanon; K Scearce-Levie; J J Lucas; B Rocha; R Hen
Journal:  Pharmacol Biochem Behav       Date:  2000-11       Impact factor: 3.533

10.  Effect of schedule of reinforcement on cue-elicited reinstatement of cocaine-seeking behavior.

Authors:  Jazmin I Acosta; Kenneth J Thiel; Federico Sanabria; Jenny R Browning; Janet L Neisewander
Journal:  Behav Pharmacol       Date:  2008-03       Impact factor: 2.293

View more
  17 in total

Review 1.  Novel pharmacotherapeutic treatments for cocaine addiction.

Authors:  Daryl Shorter; Thomas R Kosten
Journal:  BMC Med       Date:  2011-11-03       Impact factor: 8.775

2.  Stimulation of medial prefrontal cortex serotonin 2C (5-HT(2C)) receptors attenuates cocaine-seeking behavior.

Authors:  Nathan S Pentkowski; Felicia D Duke; Suzanne M Weber; Lara A Pockros; Andrew P Teer; Elizabeth C Hamilton; Kenneth J Thiel; Janet L Neisewander
Journal:  Neuropsychopharmacology       Date:  2010-06-02       Impact factor: 7.853

3.  A new criterion for acquisition of nicotine self-administration in rats.

Authors:  Natalie A Peartree; Federico Sanabria; Kenneth J Thiel; Suzanne M Weber; Timothy H C Cheung; Janet L Neisewander
Journal:  Drug Alcohol Depend       Date:  2012-01-13       Impact factor: 4.492

4.  Differential effect of viral overexpression of nucleus accumbens shell 5-HT1B receptors on stress- and cocaine priming-induced reinstatement of cocaine seeking.

Authors:  Sunila G Nair; Amy R Furay; Yusha Liu; John F Neumaier
Journal:  Pharmacol Biochem Behav       Date:  2013-09-25       Impact factor: 3.533

Review 5.  Serotonin at the nexus of impulsivity and cue reactivity in cocaine addiction.

Authors:  Kathryn A Cunningham; Noelle C Anastasio
Journal:  Neuropharmacology       Date:  2013-07-11       Impact factor: 5.250

6.  Protracted withdrawal from cocaine self-administration flips the switch on 5-HT(1B) receptor modulation of cocaine abuse-related behaviors.

Authors:  Nathan S Pentkowski; Tim H C Cheung; William A Toy; Matthew D Adams; John F Neumaier; Janet L Neisewander
Journal:  Biol Psychiatry       Date:  2012-04-27       Impact factor: 13.382

7.  Inactivation of the dorsal raphé nucleus reduces the anxiogenic response of rats running an alley for intravenous cocaine.

Authors:  Aaron Ettenberg; Oren A Ofer; Carl L Mueller; Stephanie Waldroup; Ami Cohen; Osnat Ben-Shahar
Journal:  Pharmacol Biochem Behav       Date:  2010-11-23       Impact factor: 3.533

8.  Stimulation of dopamine D2/D3 but not D1 receptors in the central amygdala decreases cocaine-seeking behavior.

Authors:  Kenneth J Thiel; Jennifer M Wenzel; Nathan S Pentkowski; Rebecca J Hobbs; Andrea T Alleweireldt; Janet L Neisewander
Journal:  Behav Brain Res       Date:  2010-06-19       Impact factor: 3.332

9.  5-HT(2A) receptor blockade and 5-HT(2C) receptor activation interact to reduce cocaine hyperlocomotion and Fos protein expression in the caudate-putamen.

Authors:  Lara A Pockros; Nathan S Pentkowski; Sineadh M Conway; Teresa E Ullman; Kimberly R Zwick; Janet L Neisewander
Journal:  Synapse       Date:  2012-09-11       Impact factor: 2.562

Review 10.  Dopamine D3 and 5-HT1B receptor dysregulation as a result of psychostimulant intake and forced abstinence: Implications for medications development.

Authors:  Janet L Neisewander; Timothy H C Cheung; Nathan S Pentkowski
Journal:  Neuropharmacology       Date:  2013-08-23       Impact factor: 5.250

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.